Finance

Lists
Why is 9606 up 10,89%?
Dive Deeper
9606:HKG
Duality Biotherapeutics Inc
170,00 HK$
+10,89%
(+16,70) 1D
16 հոկ, 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 9606...
Open
154,50 HK$
High
179,60 HK$
Low
154,50 HK$
Mkt. cap
13,57 մլրդ
Avg. vol.
770,17 հզր
Volume
1,74 մլն
52-wk high
376,80 HK$
52-wk low
151,40 HK$
EPS
-18,69 HK$
No. of employees
266
Open
154,50 HK$
High
179,60 HK$
Low
154,50 HK$
Mkt. cap
13,57 մլրդ
Avg. vol.
770,17 հզր
Volume
1,74 մլն
52-wk high
376,80 HK$
52-wk low
151,40 HK$
EPS
-18,69 HK$
No. of employees
266
News stories
From web sources and news partners
About Duality Biotherapeutics Inc
CEO-
Employees266
Founded03 հլս, 2019 թ.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
311,40 մլն
311,40 մլն
109,66 մլն
109,66 մլն
Cost of goods sold
311,55 մլն
311,55 մլն
226,34 մլն
226,34 մլն
Cost of revenue
311,55 մլն
311,55 մլն
226,34 մլն
226,34 մլն
Research and development expenses
244,19 մլն
244,19 մլն
303,33 մլն
303,33 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
44,53 մլն
44,53 մլն
40,77 մլն
40,77 մլն
Operating expense
288,00 մլն
288,00 մլն
342,03 մլն
342,03 մլն
Total operating expenses
599,55 մլն
599,55 մլն
568,37 մլն
568,37 մլն
Operating income
-288,15 մլն
-288,15 մլն
-458,70 մլն
-458,70 մլն
Other non operating income
6,86 մլն
6,86 մլն
-
-
EBT including unusual items
-260,48 մլն
-260,48 մլն
-458,77 մլն
-458,77 մլն
EBT excluding unusual items
-264,12 մլն
-264,12 մլն
-459,70 մլն
-459,70 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-722,50 հզր
-722,50 հզր
-2,08 մլն
-2,08 մլն
Net income
-260,48 մլն
-260,48 մլն
-458,77 մլն
-458,77 մլն
Net profit margin
-83,65%
-83,65%
-418,34%
-418,34%
Earnings per share
-
-
-
-
Interest and investment income
29,92 մլն
29,92 մլն
25,95 մլն
25,95 մլն
Interest expense
-318,50 հզր
-318,50 հզր
-1,27 մլն
-1,27 մլն
Net interest expenses
29,60 մլն
29,60 մլն
24,68 մլն
24,68 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-286,03 մլն
-286,03 մլն
-456,26 մլն
-456,26 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps